tirzepatide vs semaglutide weight loss trials Outperforms in Trial Phase 3 Trial shows Tirzepatide

The combination of attenuated early release and enhanced cumulative release supports a dual function of methionine in suppressing burst release while promoting prolonged delivery

Like all medications, GLP-1 drugs can cause side effects, including nausea, vomiting, diarrhea, and constipation

Brain health - The tissues in the brain may be more susceptible to oxidative stress

Reports of adverse events and dosing errors The FDA has received hundreds of adverse event reports linked to compounded versions of semaglutide and tirzepatide, including cases involving nausea, vomiting, abdominal pain, and other gastrointestinal symptoms